You are viewing the site in preview mode

Skip to main content

Table 1 Overview of the included studies

From: Reporting preclinical gene therapy studies in the field of Niemann-Pick type C disease according to the ARRIVE guidelines

Mouse model

Vector

Promoter

Dosage per mouse

Route of administration

Age at treatment

Effect

Reference

CNS

P

Viral gene therapy

Npc1nih/nih

Npc1nmf164

AAV9

GAPDH

PGK

NPC1

CBA

hSYN1

SYN-S SYN-D

CAG

1.5 × 1011 vg

Intracerebroventricular injection

PN 0–1

 + 

n.a.

[16]

BALB/cNctr-Npc1m1N/J

AAV9 and

AAV-PHP.B

EF1α

1.84 × 1012 vg AAV9

1.43 × 1012 vg AAV-PHP.B

Retro-orbital injection

PN 24–27

 + 

 + 

[11]

FVB.C-Npc1m1N/J

AAV9/3

CMV

1.35 × 1011 vg

Intracerebroventricular and intracisternal injections

PN 4–5

 + 

 + 

[12]

BALB/cNctr-Npc1m1N/J

AAV9

hSYN1

4.6 × 109 vg or

2.5 × 1011 vg

Bilateral intra-cerebroventricular

injections

PN 0–1

 + 

[15]

Npc2tm1Plob

AAVrh.10

CAG

1011 vg

Intracisternal injection

6 weeks

 + 

 + 

[14]

BALB/cNctr-Npc1m1N/J

AAV9

CMV

2.5 × 1011 vg

Intracardiac injection

PN 4

 + 

 + 

[13]

BALB/cNctr-Npc1m1N/J

AAV9

CamKII or

EF1α

2.6 × 1011 vg (neonates)

1.3 × 1012 vg

(juvenile)

Retro-orbital injection

PN 1–3

PN 20–25

 + 

 + 

[10]

Non-viral gene therapy

BALB/cNctr-Npc1m1N/J

TfRMAb targeted THLs

PDGFB

6 µg plasmid DNA and

15 µg TfRMAb

Tail-vein injection

6–7 weeks

 + 

[22]

  1. AAV Adeno-associated virus, GAPDH glyceraldehyde-3-phosphate dehydrogenase, PGK phosphoglycerate kinase, NPC1 small, truncated version of the endogenous human NPC1 promoter, CBA chicken β-actin, hSYN1 human synapsin 1, SYN-D neuron de-targeted synapsin-1, SYN-S shortened synapsin-1, CAG chicken β-actin promoter with CMV enhancer, EF1α: elongation factor 1α, CMV cytomegalovirus, CamKII: calcium/calmodulin-dependent protein kinase II, TfrMAb targeted THLs Transferrin receptor-specific monoclonal antibody conjugated to THLs Trojan horse liposomes, PDGFB human platelet-derived growth factor B, vg viral genomes, PN postnatal day, CNS central nervous system, P peripheral, n.a. not assessed